KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Preferred Stock Liabilities: 2010-2016

Historic Preferred Stock Liabilities for Teva Pharmaceutical Industries (TEVA) over the last 6 years, with Dec 2016 value amounting to -$811.0 million.

  • Teva Pharmaceutical Industries' Preferred Stock Liabilities rose 0.12% to -$822.0 million in Q1 2017 from the same period last year, while for Mar 2017 it was -$822.0 million, marking a year-over-year increase of 0.12%. This contributed to the annual value of -$811.0 million for FY2016, which is 200.00% down from last year.
  • According to the latest figures from FY2016, Teva Pharmaceutical Industries' Preferred Stock Liabilities is -$811.0 million, which was down 200.00% from $811.0 million recorded in FY2015.
  • In the past 5 years, Teva Pharmaceutical Industries' Preferred Stock Liabilities ranged from a high of $811.0 million in FY2015 and a low of -$811.0 million during FY2016.
  • Its 2-year average for Preferred Stock Liabilities is $0, with a median of $0 in 2015.
  • Its Preferred Stock Liabilities has fluctuated over the past 5 years, first rose by 29.50% in 2012, then plummeted by 254.08% in 2013.
  • Teva Pharmaceutical Industries' Preferred Stock Liabilities (Yearly) stood at -$98.0 million in 2012, then crashed by 254.08% to -$347.0 million in 2013, then reached $811.0 million in 2015, then crashed by 200.00% to -$811.0 million in 2016.